Hernández SJ

Language: Spanish
References: 17
Page: 189-193
PDF size: 306.58 Kb.

ABSTRACT

Diabetes mellitus is a disease of high prevalence in our country, with complications that cause a great impact on patient autonomy. It is a public health problem, both by the large number of deaths it causes, and by the limitations and the consequences on life´s quality of patients. It is a disease with a high economic cost, which grows more every year because more patients are being diagnosed. But not only is the direct economic costs of illness, because they are also complications like ulcers, amputations, neuropathy, loss of protective sense, among others, to further increase this figure. That´s why apart from glycemic control, it is vital that we find complementary therapies to prevent, reduce or treat these complications more effectively, thus improving the quality of life and autonomy of patients, leading to a decrease in the costs involved this disease. In the next review, we introduce a therapy that has been used for several years with very positive results. This is infrared therapy, a noninvasive, painless, without complications, which has come to bring major changes in diabetic´s lives.

REFERENCES

1. Anodyne Therapy. Monochromatic Infrared Photo Energy (MIRE) – A Data Review of Various Published Outcomes Measures in Diabetic Peripheral Neuropathy After Treatment with MIRE. Business Briefing: N Am Pharmacother. 2005

2. Anodyne theraphy. En: www.anodynetherapy.com

3. Burke T, Kochman A. Improved Sensory Perception in Diabetes. Am Diabetes Assoc. June 2001 Annual Meeting.

4. Burke T. Infrared Photo Energy May Reduce Neuropathic Pain. Practical Pain Manag. July/August 2007.

5. DeLellis S, et al. Improved Sensitivity in Patients with Peripheral Neuropathy: Effects of Monochromatic Infrared Photo Energy. J Am Podiatr Med Assoc. 2005. 95(2): 143-147.

6. Harkless L, DeLellis S, Carnegie D, Burke T. Improved foot sensitivity and pain reduction in patients with peripheral neuropathy after treatment with monochromatic infrared photo energy—MIRE. J Diabetes Complications. 20 (2006) 81– 87

7. Hieronymus L, Bordes J. Diabetic Peripheral Neuropathy. Diabetes Basics. Diabetes Self Manag. September-October 2007.

8. Horwitz L, Burke T, Carnegie D. Augmentation of Wound Healing Using Monochromatic Infrared Energy. Adv Wound Care 1999; 12:35-40.

9. Jie L, Cheng X, Zhong S. Treatment Effect Observation: Monochromatic Near-Infrared Photo Energy (MIRE) Effective Treatment for Diabetic Peripheral Neuropathy. Department of Endocrine of Mid-South Hospital at Wu Han University. Chin J Diabetes Educ. July 2005

10. Kochman A. Monochromatic Infrared Photo Energy and Physical Therapy for Peripheral Neuropathy: Influence on Sensation, Balance and Falls. J Geriatr Phys Ther. Vol. 27;1:04.

11. Kochman A, Carnegie D, Burke T. Symptomatic Reversal of Peripheral Neuropathy in Patients with Diabetes. J Am Podiatr Med Assoc. Vol 92. No 3. March 2002.

12. Leonard D, Hamed M, Myers S. Restoration of Sensation, Reduced Pain, and Improved Balance in Subjects With Diabetic Peripheral Neuropathy. Diabetes Care. 2004. 27:168–172

13. Moncada S, Higgs A. Mechanisms of Disease: The L-Arginine-Nitric Oxide Pathway. N Engl J Med. Volume 329(27), Dec 30, 1993 pg. 2002-2012.

14. Nather A, Sim Y, Chew L, SH Neo. Anodyne therapy for recalcitrant diabetic foot ulcers: a report of four cases. J Orthop Surg. 2007; 15(3):361-4.

15. Powell M, Carnegie D, Burke T. Reversal of Diabetic Peripheral Neuropathy and New Wound Incidence: The Role of MIRE. Adv Skin Wound Care. 2004; 17:295-6, 298-300.

16. Powell M, Carnegie D, Burke T. Reversal of diabetic peripheral neuropathy with phototherapy (MIRE™) decreases falls and the fear of falling and improves activities of daily living in seniors. Age Ageing. 2006; 35: 11–16

17. Prendergast J, Miranda G, Sanchez M. Improvement of Sensory Impairment in Patients with Peripheral Neuropathy. Endocr Pract. January/February 2004. 10:24-30